IMMUNE-RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS: THE DEBRECEN EXPERIENCE

Szekanecz, Zoltán; Sebestyén, Enikő; Major, Nóra; Bodoki, Levente; Makai, Attila; Balogh, Ingrid; Tóth, Gábor; Orosz, Zsuzsanna; Árkosy, Péter; Vaskó, Attila; Hodosi, Katalin; Szekanecz, Éva

doi:10.33004/reumatizam-supp-70-1-10

Reumatizam, Vol. 70 No. Supp 1, 2023.

Sažetak sa skupa

https://doi.org/10.33004/reumatizam-supp-70-1-10

IMMUNE-RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS: THE DEBRECEN EXPERIENCE

Zoltán Szekanecz ; 1University of Debrecen, Faculty of Medicine, Departments of Rheumatology, Debrecen, Hungary
Enikő Sebestyén
Nóra Major
Levente Bodoki
Attila Makai
Ingrid Balogh
Gábor Tóth
Zsuzsanna Orosz
Péter Árkosy
Attila Vaskó
Katalin Hodosi
Éva Szekanecz

Puni tekst: engleski pdf 982 Kb

str. 10-10

preuzimanja: 112

citiraj

APA 6th Edition

Szekanecz, Z., Sebestyén, E., Major, N., Bodoki, L., Makai, A., Balogh, I., ... Szekanecz, É. (2023). IMMUNE-RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS: THE DEBRECEN EXPERIENCE. Reumatizam, 70 (Supp 1), 10-10. https://doi.org/10.33004/reumatizam-supp-70-1-10

MLA 8th Edition

Szekanecz, Zoltán, et al. "IMMUNE-RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS: THE DEBRECEN EXPERIENCE." Reumatizam, vol. 70, br. Supp 1, 2023, str. 10-10. https://doi.org/10.33004/reumatizam-supp-70-1-10. Citirano 23.12.2024.

Chicago 17th Edition

Szekanecz, Zoltán, Enikő Sebestyén, Nóra Major, Levente Bodoki, Attila Makai, Ingrid Balogh, Gábor Tóth, et al. "IMMUNE-RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS: THE DEBRECEN EXPERIENCE." Reumatizam 70, br. Supp 1 (2023): 10-10. https://doi.org/10.33004/reumatizam-supp-70-1-10

Harvard

Szekanecz, Z., et al. (2023). 'IMMUNE-RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS: THE DEBRECEN EXPERIENCE', Reumatizam, 70(Supp 1), str. 10-10. https://doi.org/10.33004/reumatizam-supp-70-1-10

Vancouver

Szekanecz Z, Sebestyén E, Major N, Bodoki L, Makai A, Balogh I i sur. IMMUNE-RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS: THE DEBRECEN EXPERIENCE. Reumatizam [Internet]. 2023 [pristupljeno 23.12.2024.];70(Supp 1):10-10. https://doi.org/10.33004/reumatizam-supp-70-1-10

IEEE

Z. Szekanecz, et al., "IMMUNE-RELATED ADVERSE EVENTS OF IMMUNE CHECKPOINT INHIBITORS: THE DEBRECEN EXPERIENCE", Reumatizam, vol.70, br. Supp 1, str. 10-10, 2023. [Online]. https://doi.org/10.33004/reumatizam-supp-70-1-10

Sažetak

Ključne riječi

checkpoint inhibitors, immune-related, adverse events

Hrčak ID:

309335

URI

https://hrcak.srce.hr/309335

Datum izdavanja:

16.10.2023.

Posjeta: 295 *

Prijava i registracija

Reumatizam, Vol. 70 No. Supp 1, 2023.

Sažetak

Ključne riječi

Hrčak ID:

URI

Datum izdavanja: